COST Action CA18218

Action dissemination

Publications

 

Mortality burden of cardiovascular disease attributable to ambient PM2.5 exposure in Portugal, 2011 to 2021
Corda MO, Charalampous P, Haagsma JA, Assunção R, Martins C
BMC Public Health. 2024;24(1):1188

 

The direct disease burden of COVID-19 in Belgium in 2020 and 2021
Devleesschauwer B, Willem L, Jurčević J, Smith P, Scohy A, Wyper GMA, Pires SM, Van Goethem N, Van Cauteren D, Speybroeck N, Hens N, De Pauw R
BMC Public Health. 2023;23(1):1707

 

The burden of breast, cervical, and colon and rectum cancer in the Balkan countries, 1990-2019 and forecast to 2030
Todorovic J, Stamenkovic Z, Stevanovic A, et al.
Arch Public Health. 2023;81(1):156

 

Investigating years of life lost in Belgium, 2004–2019: A comprehensive analysis using a probabilistic redistribution approach
Devleesschauwer B, Scohy A, De Pauw R, Gorasso V, Kongs A, Neirynck E, Verduyckt P, Wyper GMA, Van den Borre L
Arch Public Health. 2023;81(1):160

 

Burden of disease attributable to risk factors in European countries: a scoping literature review
Gorasso V, Morgado JN, Charalampous P, et al.
Arch Public Health. 2023;81(1):116

 

Certainty of the Global Burden of Disease 2019 Modelled Prevalence Estimates for Musculoskeletal Conditions: A Meta-Epidemiological Study
Laguna JM, Puhan M, Artalejo FR, De Pauw R, Wyper GMA, Devleesschauwer B, Santos JV, Hincapié CA
Int J Public Health. 2023;68:1605763

 

An EU task force to assess the burden of rare diseases
Kolkhir P, Grad DA, Charalampous P, Oliveira CC, Mechili EA, Unim B, Pearce DA, Maurer M, Devleesschauwer B, Haagsma J
Nat Med. 2023;29(3):516-517

 

Direct impact of COVID-19 by estimating disability-adjusted life years at national level in France in 2020
Haneef R, Fayad M, Fouillet A, Sommen C, Bonaldi C, Wyper GMA, Pires SM, Devleesschauwer B, Rachas A, Constantinou P, Levy-Bruhl D, Beltzer N, Gallay A
PLOS ONE. 2023;10:907012

 

Burden of infectious disease studies in Europe and the United Kingdom: a review of methodological design choices
Charalampous P, Haagsma JA, Jakobsen LS, et al.
Epidemiol Infect. 2023;in press

 

Burden of disease among older adults in Europe—trends in mortality and disability, 1990–2019
Iburg KM, Charalampous P, Allebeck P, Stenberg EJ, O’Caoimh R, Monasta L, Peñalvo JL, Pereira DM, Wyper GMA, Niranjan V, Devleesschauwer B, Haagsma J
Eur J Public Health. 2022;33(1):121-126

 

Mortality comparisons of COVID-19 with all-cause and non-communicable diseases in Cyprus, Iceland and Malta: lessons learned and forward planning
Cuschieri S, Pallari E, Hatziyianni A, Sigurvinsdottir R, Sigfusdottir ID, Sigurðardóttir ÁK
Public Health. 2022;202:52-57

 

Re-engineering the Cypriot General Healthcare System for Syndemics
Cuschieri S, Hatziyianni A, Karayiannis P, Haagsma JA, Wyper GMA, Kantaris M, Theodorou M, Pallari E
Front Public Health. 2022;10:734796

 

A year of Covid-19: experiences and lessons learnt by small European island states—Cyprus, Iceland and Malta
Cuschieri S, Pallari E, Hatziyianni A, Sigurvinsdottir R, Sigfusdottir ID, Sigurðardóttir AK
Eur J Public Health. 2022;32(2):316-321

 

Methodological considerations in injury burden of disease studies across Europe: a systematic literature review
Charalampous P, Pallari E, Gorasso V, et al
BMC Public Health. 2022;80:142

 

Burden of Disease of COVID-19: Strengthening the Collaboration for National Studies
Pires SM, Wyper GMA, Wengler A, Peñalvo JL, Haneef R, Moran D, Cuschieri S, Redondo HG, De Pauw R, McDonald SA, Moon L, Shedrawy J, Pallari E, Charalampous P, Devleesschauwer B, von Der Lippe E
Front Public Health. 2022;10:907012

 

Estimating the Direct Disability-Adjusted Life Years Associated With SARS-CoV-2 (COVID-19) in the Republic of Ireland: The First Full Year
Moran DP, Pires SM, Wyper GMA, Devleesschauwer B, Cuschieri S, Kabir Z
Int J Public Health. 2022;67:1604699

 

Estimating risk factor attributable burden – challenges and potential solutions when using the comparative risk assessment methodology
Plass D, Hilderink H, Lehtomäki H, Øverland S, Eikemo TA, Lai T, Gorasso V, Devleesschauwer B
Arch Public Health. 2022;80:148

 

Measuring disability-adjusted life years (DALYs) due to COVID-19 in Scotland, 2020
Wyper GMA, Fletcher E, Grant I, McCartney G, Fischbacher C, Harding O, Jones H, de Haro Moro MT, Speybroeck N, Devleesschauwer B, Stockton DL
Arch Public Health. 2022;80:105

 

A systematic literature review of disability weights measurement studies: evolution of methodological choices
Charalampous P, Polinder S, Wothge J, von der Lippe E, Haagsma JA
Arch Public Health. 2022;80:91

 

Years of life lost methods must remain fully equitable and accountable
Wyper GMA, Devleesschauwer B, Mathers CD, McDonald SA, Speybroeck N
Eur J Epidemiol. 2022;37:215–216

 

The non-fatal burden of cancer in Belgium, 2004–2019: a nationwide registry-based study
Gorasso V, Silversmit G, Arbyn M, Cornez A, De Pauw R, De Smedt D, Grant I, Wyper GMA, Devleesschauwer B, Speybroeck N
BMC Cancer. 2022;22:58

 

Burden of non-communicable disease studies in Europe: a systematic review of data sources and methodological choices
Charalampous P, Gorasso V, Plass D, Pires SM, von der Lippe E, Mereke A, Idavain J, Kissimova-Skarbek K, Morgado JN, Ngwa CH, Noguer I, Padron-Monedero A, Santi-Cano MJ, Sarmiento R, Devleesschauwer B, Haagsma JA, The COST Action CA18218 participants
Eur J Public Health. 2022;32(2):289–296

 

Mapping the burden of diabetes in five small countries in Europe and setting the agenda for health policy and strategic action
Cuschieri S, Pallari E, Terzic N, Alkerwi A, Sigurðardóttir ÁK
Health Res Policy Syst. 2021;19(1):43

 

Estimating the direct Covid-19 disability-adjusted life years impact on the Malta population for the first full year
Cuschieri S, Calleja N, Devleesschauwer B, Wyper GMA
BMC Public Health. 2021;21(1):1827

 

Risk factors and their contribution to population health in the European Union (EU-28) countries in 2007 and 2017
Santos JV, Gorasso V, Souza J, Wyper GMA, Grant I, Pinheiro V, Viana J, Ricciardi W, Haagsma JA, Devleesschauwer B, Plass D, Freitas A
Eur J Public Health. 2021;31(5):958-967

 

Burden of non-communicable diseases in Cyprus, 1990–2017: findings from the Global Burden of Disease 2017 study
Charalampous P, Pallari E, Tyrovolas S, Middleton N, Economou M, Devleesschauwer B, Haagsma JA
Arch Public Health. 2021;79:138

 

Recommendations to plan a national burden of disease study
Haneef R, Schmidt J, Gallay A, Devleesschauwer B, Grant I, Rommel A, Wyper GMA, van Oyen H, Hilderink H, Ziese T, Newton J
Arch Public Health. 2021;79:126

 

The increasing significance of disease severity in a burden of disease framework
Wyper G, Assunçao R, Fletcher E, Gourley M, Grant I, Haagsma J, Hilderink H, Idavain J, Lesnik T, von der Lippe E, Majdan M, McCartney G, Pallari E, Pires S, Plass D, Porst M, Santos J, Santric-Milicevic M, de Haro Moro MT, Stockton D, Devleesschauwer B
Scand J Public Health. 2023;51(2):296-300

 

Health expectancies in the European Union: same concept, different methods, different results
Santos JV, Viana J, Devleesschauwer B, Haagsma J, Costa-Santos C, Ricciardi W, Freitas A
J Epidemiol Community Health. 2021;75:764-771

 

Burden of foodborne diseases: think global, act local
Pires SM, Desta BN, Mughini-Gras L, Mmbaga BT, Fayemi OE, Salvador EM, Gobena T, Majowicz SE, Hald TM, Hoejskov PS, Minato Y, Devleesschauwer B
Curr Opin Food Sci. 2021;39:152-159

 

Conducting national burden of disease studies in small countries in Europe– a feasible challenge?
Cuschieri S, Pallari E, Terzic N, Alkerwi A, Sigurvinsdottir R, Sigfusdottir ID, Devleesschauwer B
Arch Public Health. 2021;79:73

 

Burden of disease methods: a guide to calculate COVID-19 disability-adjusted life years
Wyper GMA, Assunçao RMA, Colzani E, Grant I, Haagsma JA, Lagerweij G, Von der Lippe E, McDonald SA, Pires SM, Porst M, Speybroeck N, Devleesschauwer B
Int J Public Health. 2021;66:619011

 

Reflections on key methodological decisions in national burden of disease assessments
von der Lippe E, Devleesschauwer B, Gourley M, Haagsma J, Hilderink H, Porst M, Wengler A, Wyper G, Grant I
Arch Public Health. 2020;78:137

 

Measuring disability-adjusted life years (DALYs) due to low back pain in Malta
Cuschieri S, Wyper GMA, Calleja N, Gorasso V, Devleesschauwer B
Arch Public Health. 2020;78:68

 

Valuing the years of life lost due to COVID-19: the differences and pitfalls.
Devleesschauwer B, McDonald S, Speybroeck N, Wyper GMA
Int J Public Health. 2020;65:719-720

 

Population vulnerability to COVID-19 in Europe: a burden of disease analysis
Wyper GM, Assunção RM, Cuschieri S, Devleeschauwer B, Fletcher E, Haagsma JA, Hilderink H, Idavain J, Lesnik T, Von der Lippe E, Majdan M, Santric-Milicevic M, Pallari E, Peñalvo JL, Pires SM, Plass D, Santos JV, Stockton DL, Thomsen ST, Grant I
Arch Public Health. 2020;78:47

 

European burden of disease network: strengthening the collaboration
Devleesschauwer B
Eur J Public Health. 2020;30:2-3

 

Workshops

National burden of disease studies: inspirational experiences from across the globe
16th World Congress on Public Health, online event, 2020
The French national Global Burden of Disease (GBD) evaluation project
— Anne Gallay, Santé Publique France, France
Download the presentation  •  View the abstract
The experience of the Italian Global Burden of Disease Initiative
— Lorenzo Monasta, Institute for Maternal and Child Health - IRCCS Burlo Garofolo, Italy
Download the presentation  •  View the abstract
The power of administrative data in national studies: experiences from the Scottish Burden of Disease study
— Ian Grant, Public Health Scotland, UK
Download the presentation  •  View the abstract
Conducting a national burden of disease study in South Korea: from past to present
— Seok-Jun Yoon, Korea University, South Korea
Download the presentation  •  View the abstract
Key developments and results from the Australian Burden of Disease Study
— Michelle Gourley, Australian Institute of Health and Welfare, Australia
Download the presentation  •  View the abstract
Burden of foodborne disease: methods and relevance of national studies
16th World Congress on Public Health, online event, 2020
Burden of Foodborne Disease in the Netherlands: from science to policy
— Lapo Mughini Gras, National Institute for Public Health and the Environment, Netherlands
Download the presentation  •  View the abstract
Estimating burden of foodborne diseases where public health impact is higher and data scarcer: a study in four African countries
— Binyam Desta, University of Waterloo, Canada
Download the presentation  •  View the abstract
Using novel methodologies to support burden of disease estimates
— Tine Hald, National Food Institute, Denmark
Download the presentation  •  View the abstract
Capacity building and support from international organizations
— Peter Hoejskov, WHO European Regional Office, Denmark
Download the presentation  •  View the abstract
European burden of disease network: strengthening the collaboration
16th World Congress on Public Health, online event, 2020
Unscattering the burden of disease landscape: supporting interaction between existing burden of disease efforts
— Juanita Haagsma, Erasmus MC, Netherlands
Download the presentation  •  View the abstract
Fostering methodological advances and technical capacity building
— Ian Grant, Public Health Scotland, UK
Download the presentation  •  View the abstract
Knowledge translation and health policy for burden of disease
— Elena Pallari, Cube Integrated Engineering, Cyprus
Download the presentation  •  View the abstract
Deconstructing the DALY: step by step guide to calculating YLL and YLD
16th World Congress on Public Health, online event, 2020
Data inputs and assumptions in calculating the fatal burden in burden of disease studies
— Elena von der Lippe, Robert Koch Institute, Germany
Download the presentation  •  View the abstract
Data inputs and assumptions in calculating the non-fatal burden in burden of disease studies
— Juanita Haagsma, Erasmus MC, Netherlands
Download the presentation  •  View the abstract
Environmental Burden of Disease: methods and applications
12th European Public Health Conference, Marseille, France, 21-23 November 2019
Introduction to the Environmental Burden of Disease concept – history, methods and selected results
— Dietrich Plass, Myriam Tobollik & Dirk Wintermeyer, German Environment Agency, Germany
Download the presentation  •  View the abstract
Environmental Burden of Disease in the Netherlands
— Henk Hilderink, Dieneke Schram & Marjanne Plasmans, National Institute for Public Health and the Environment, Netherlands
Download the presentation  •  View the abstract
Burden of disease due to nitrogen dioxide exposure in Germany
— Dietrich Plass, Myriam Tobollik & Dirk Wintermeyer, German Environment Agency, Germany
Download the presentation  •  View the abstract
Burden of disease of heavy metals in population clusters: towards targeted public health strategies
— Sofie Theresa Thomsen, José Alejandro Herrera Romero, Lea Sletting Jakobsen, Sisse Fagt & Sara Monteiro Pires, National Food Institute, Denmark
Download the presentation  •  View the abstract

About COST

COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. COST Actions help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation. Read more via cost.eu.

Get in touch

COST logo

Funded by the European Union

Website by  woluweb mini